Published in Neonatology on September 11, 2008
Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention? Pediatr Res (2009) 1.32
Inter-alpha inhibitor protein level in neonates predicts necrotizing enterocolitis. J Pediatr (2010) 0.98
Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey. BMC Pediatr (2011) 0.95
The role of calprotectin in pediatric disease. Biomed Res Int (2013) 0.93
Fecal calprotectin excretion in preterm infants during the neonatal period. PLoS One (2010) 0.90
What really causes necrotising enterocolitis? ISRN Gastroenterol (2012) 0.88
Evaluation of potential factors predicting attainment of full gavage feedings in preterm infants. Neonatology (2010) 0.88
Red blood cell transfusions increase fecal calprotectin levels in premature infants. J Perinatol (2015) 0.81
Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants. Neonatology (2013) 0.77
Relationships of Feeding and Mother's Own Milk with Fecal Calprotectin Levels in Preterm Infants. Breastfeed Med (2016) 0.77
Serum Calprotectin: A Potential Biomarker for Neonatal Sepsis. J Immunol Res (2015) 0.76
Elevated fecal calprotectin levels during necrotizing enterocolitis are associated with activated neutrophils extruding neutrophil extracellular traps. J Perinatol (2016) 0.75
Calprotectin: Clinical Applications in Pediatrics. J Pediatr Pharmacol Ther (2016) 0.75
Blood Level of Inter-Alpha Inhibitor Proteins Distinguishes Necrotizing Enterocolitis From Spontaneous Intestinal Perforation. J Pediatr (2016) 0.75
Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol (1999) 2.02
Intestinal permeability in the newborn. Arch Dis Child (1984) 1.94
Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion (1997) 1.92
Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr (1991) 1.55
Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol (1985) 1.53
Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. Clin Chem (2003) 1.50
Improved assay for fecal calprotectin. Clin Chim Acta (2000) 1.49
Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr (2002) 1.47
Gut responses to enteral nutrition in preterm infants and animals. Exp Biol Med (Maywood) (2006) 1.29
Gut hormones and 'minimal enteral feeding'. Acta Paediatr Scand (1986) 1.23
Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet (2003) 1.21
Variations in incidence of necrotizing enterocolitis in Canadian neonatal intensive care units. J Pediatr Gastroenterol Nutr (2004) 1.14
Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr (2007) 1.11
Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr (2002) 1.08
High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed (2004) 1.02
Enteral nutrients promote postnatal maturation of intestinal motor activity in preterm infants. Am J Physiol (1993) 1.01
Fecal calprotectin in healthy term and preterm infants. J Pediatr Gastroenterol Nutr (2004) 0.97
Current issues in the management of necrotizing enterocolitis. Semin Perinatol (2004) 0.96
Postnatal changes in mucosal immune response: a physiological perspective of breast feeding and weaning. Immunol Cell Biol (1997) 0.91
Early feeding, feeding tolerance, and lactase activity in preterm infants. J Pediatr (1998) 0.86
Minimal enteral feedings. Clin Perinatol (1995) 0.85
Calprotectin levels in meconium. Acta Paediatr (2003) 0.84
Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med (2005) 13.96
Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics (2010) 9.15
Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med (2010) 6.86
Sports medicine and ethics. Am J Bioeth (2013) 5.51
Early CPAP versus surfactant in extremely preterm infants. N Engl J Med (2010) 5.23
Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics (2011) 3.84
Dynamics of human foveal development after premature birth. Ophthalmology (2011) 3.11
Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics (2009) 3.05
Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics (2006) 2.98
An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr (2009) 2.89
Between-hospital variation in treatment and outcomes in extremely preterm infants. N Engl J Med (2015) 2.59
Globalization of pediatric research: analysis of clinical trials completed for pediatric exclusivity. Pediatrics (2010) 2.48
Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med (2011) 2.31
Optimizing hand-held spectral domain optical coherence tomography imaging for neonates, infants, and children. Invest Ophthalmol Vis Sci (2010) 2.11
The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics (2006) 2.10
Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? Pediatrics (2006) 1.98
Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. Lancet (2002) 1.93
Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation. JAMA (2011) 1.92
Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J (2009) 1.90
Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy. Pediatrics (2008) 1.89
Clinical seizures in neonatal hypoxic-ischemic encephalopathy have no independent impact on neurodevelopmental outcome: secondary analyses of data from the neonatal research network hypothermia trial. J Child Neurol (2010) 1.87
Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics (2010) 1.86
Brain injury following trial of hypothermia for neonatal hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed (2012) 1.69
Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy. J Pediatr (2010) 1.67
Pediatric antihypertensive trial failures: analysis of end points and dose range. Hypertension (2008) 1.65
Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections. Clin Infect Dis (2012) 1.63
Cardiopulmonary bypass is associated with hemolysis and acute kidney injury in neonates, infants, and children*. Pediatr Crit Care Med (2014) 1.63
Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J (2012) 1.63
End-tidal and arterial carbon dioxide measurements correlate across all levels of physiologic dead space. Respir Care (2010) 1.56
Traumatic lumbar punctures in neonates: test performance of the cerebrospinal fluid white blood cell count. Pediatr Infect Dis J (2008) 1.55
Antifungal therapy and outcomes in infants with invasive Candida infections. Pediatr Infect Dis J (2012) 1.53
No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants. Pediatr Infect Dis J (2015) 1.53
Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med (2008) 1.49
Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med (2015) 1.48
Safety of sildenafil in infants*. Pediatr Crit Care Med (2014) 1.42
Predicting outcomes of neonates diagnosed with hypoxemic-ischemic encephalopathy. Pediatrics (2006) 1.41
Isoflurane for life-threatening bronchospasm: a 15-year single-center experience. Respir Care (2012) 1.39
Bias flow does not affect ventilation during high-frequency oscillatory ventilation in a pediatric animal model of acute lung injury. Pediatr Crit Care Med (2012) 1.38
Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis. J Pediatr Gastroenterol Nutr (2010) 1.35
Late-onset sepsis in very low birth weight infants from singleton and multiple-gestation births. J Pediatr (2013) 1.29
Prolonged hospital stay for extremely premature infants: risk factors, center differences, and the impact of mortality on selecting a best-performing center. J Perinatol (2005) 1.29
Beyond bacteria: a study of the enteric microbial consortium in extremely low birth weight infants. PLoS One (2011) 1.28
Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants. Pediatrics (2008) 1.26
Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants. Antimicrob Agents Chemother (2012) 1.23
Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. J Infect Dis (2012) 1.23
Migraine therapeutics in adolescents: a systematic analysis and historic perspectives of triptan trials in adolescents. JAMA Pediatr (2013) 1.23
Inhaled ethyl nitrite prevents hyperoxia-impaired postnatal alveolar development in newborn rats. Am J Respir Crit Care Med (2007) 1.23
Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J Pediatr (2013) 1.22
Predicting time to hospital discharge for extremely preterm infants. Pediatrics (2009) 1.21
Individual and center-level factors affecting mortality among extremely low birth weight infants. Pediatrics (2013) 1.19
Coagulase-negative staphylococcal infections in the neonatal intensive care unit. Infect Control Hosp Epidemiol (2011) 1.19
Approach to infants born at 22 to 24 weeks' gestation: relationship to outcomes of more-mature infants. Pediatrics (2012) 1.18
Cytokines and neurodevelopmental outcomes in extremely low birth weight infants. J Pediatr (2011) 1.16
Fluconazole loading dose pharmacokinetics and safety in infants. Pediatr Infect Dis J (2011) 1.14
Evolution of encephalopathy during whole body hypothermia for neonatal hypoxic-ischemic encephalopathy. J Pediatr (2011) 1.09
Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics (2014) 1.08
Use of the complete blood cell count in early-onset neonatal sepsis. Pediatr Infect Dis J (2012) 1.07
Population pharmacokinetics of micafungin in neonates and young infants. Antimicrob Agents Chemother (2010) 1.06
Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. J Allergy Clin Immunol (2013) 1.06
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants. Pediatr Infect Dis J (2013) 1.06
Reversible retinal edema in an infant with neonatal hemochromatosis and liver failure. J AAPOS (2011) 1.05
Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants. Pediatr Infect Dis J (2010) 1.05
Mechanical ventilation strategies in the management of congenital diaphragmatic hernia. Semin Pediatr Surg (2007) 1.04
Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia. J Infect Dis (2011) 1.02
Adverse events associated with meropenem versus imipenem/cilastatin therapy in a large retrospective cohort of hospitalized infants. Pediatr Infect Dis J (2013) 1.02
Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis. J Pediatr (2012) 1.02
Antibiotic use and misuse in the neonatal intensive care unit. Clin Perinatol (2011) 1.01
The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. J Clin Microbiol (2010) 1.01
Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants. Antimicrob Agents Chemother (2014) 1.01
Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study. Clin Infect Dis (2011) 1.00
Use of antihypotensive therapies in extremely preterm infants. Pediatrics (2013) 0.99
Comparative effectiveness of surfactant preparations in premature infants. J Pediatr (2013) 0.99
Center variation in patient age and weight at Fontan operation and impact on postoperative outcomes. Ann Thorac Surg (2011) 0.98
Catheter dwell time and CLABSIs in neonates with PICCs: a multicenter cohort study. Pediatrics (2013) 0.98
Methicillin-resistant Staphylococcus aureus outbreak in an intensive care nursery: potential for interinstitutional spread. Pediatr Infect Dis J (2007) 0.97
Protocolized approach to the management of congenital diaphragmatic hernia: benefits of reducing variability in care. J Pediatr Surg (2010) 0.97
Temperature profile and outcomes of neonates undergoing whole body hypothermia for neonatal hypoxic-ischemic encephalopathy. Pediatr Crit Care Med (2012) 0.97
Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates. Clin Perinatol (2012) 0.96
Safety and transparency of pediatric drug trials. Arch Pediatr Adolesc Med (2009) 0.95
Pharmacokinetics and tolerability of single-dose daptomycin in young infants. Pediatr Infect Dis J (2012) 0.95
Safety and effectiveness of indomethacin versus ibuprofen for treatment of patent ductus arteriosus. Am J Perinatol (2009) 0.94
Arrhythmias in patients with hypoplastic left heart syndrome. Am Heart J (2011) 0.94
Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding. Biopharm Drug Dispos (2011) 0.93
Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy. Genet Med (2011) 0.92